NEW YORK (GenomeWeb) – Investment bank Evercore ISI said today that it has initiated coverage of Abbott with an Outperform rating and target price of $64 per share, Hologic with an Outperform rating and a target price of $50 per share, and Becton Dickinson with an Outperform rating and a target price of $245 per share.

Evercore ISI analyst Vijay Kumar said that initiating coverage of the three diagnostic companies coincides with re-initiating coverage of the medical technology (MedTech) sector.